IP Verse

Immunogenic Mutant Peptide Screening Platform

Patent No. EP3194970 (titled "Immunogenic Mutant Peptide Screening Platform") was filed by F Hoffmann LA Roche on Sep 10, 2015. The application was issued on Jul 28, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BISCHOF & PARTNER RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBBApr 27, 2022-

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3194970

F HOFFMANN LA ROCHE
Application Number
EP15772084A
Filing Date
Sep 10, 2015
Status
Granted And Under Opposition
Jun 25, 2021
Publication Date
Jul 28, 2021
External Links
Slate, Register , Google Patents